Decoding the cellular and molecular mechanisms of epileptogenesis and disease progression in mTORopathies
- Institution
- UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
- Principal investigator
- Yu Wang
- Funding
- $519K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
ABSTRACT mTORopathies, such as focal cortical dysplasia type II (FCDII), is the most common underlying pathology in children with drug-resistant epilepsies. However, the underlying mechanisms of epileptogenesis, hyperexcitability, and disease progression remain largely elusive. In this proposal, we combine animal models and resected human tissues to understand the cellular and molecular logic networks in the dysplastic cortex. We use cutting-edge technologies in molecular genetics, electrophysiology, transgenics, and RNA sequencing to provide conceptual insights broadly relevant to understanding mTOR-related epilepsies. Our central hypothesis is that a sustained neurotoxic microenvironment mediated by complement component C3 progressively sculpts cellular and molecular architectures, impair cortical inhibitory circuits, and promote epileptogenicity in the malformed cortex.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Michigan at Ann Arbor70
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial
Frederick Kofi Korley · $559K · 2020–2027
- NIH · University of Michigan at Ann Arbor64
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
Hiroko Hayama Dodge · $733K · 2021–2027
- NIH · University of Michigan at Ann Arbor63
Role of Adaptive Myelination in Auditory Brain Plasticity
Jun Hee Kim · $511K · 2021–2027